SCHEMBL19783196

SCHEMBL19783196

Nc1nc2cc(F)c(OCCO)nc2s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.42
PI4KA P42356 3/20 0.42
PI4KB Q9UBF8 3/20 0.42
PIK3CD O00329 2/20 0.42
PIK3CB P42338 2/20 0.42
PIK3CG P48736 1/20 0.42
ALOX5AP P20292 2/20 0.33
FEN1 P39748 2/20 0.33
AXL P30530 1/20 0.33
GFER P55789 1/20 0.33
IKBKB O14920 1/20 0.33
DHPS P49366 3/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
ACACB O00763 6/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19783052 0.83 ACACB (0.32) CA1CA2CA4ACACB
SCHEMBL21379557 0.80 ACACB (0.39) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL30189840 0.80 ACACB (0.39) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL21379555 0.80 ACACB (0.39) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL19782789 0.77 CYP3A4 (0.41) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL19782765 0.77 ALOX5AP (0.37) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL19783197 0.77 ACACB (0.34) ACACB
SCHEMBL19783056 0.73 GAA (0.42) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL19782762 0.72 ACACB (0.33) PIK3CAPI4KAPI4KBPIK3CDPIK3CB
SCHEMBL30189518 0.72 ACACB (0.33) PIK3CAPI4KAPI4KBPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed